Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 106 articles:
HTML format
Text format



Single Articles


    May 2018
  1. ABBASI J
    For Patients With Type 2 Diabetes, What's the Best Target Hemoglobin A1C?
    JAMA. 2018 May 30. pii: 2683543. doi: 10.1001/jama.2018.5420.
    PubMed     Text format    


  2. HEWITT DB, Barnard C, Bilimoria KY
    Improving Emergency Insulin Administration-Reply.
    JAMA. 2018;319:1937-1938.
    PubMed     Text format    


  3. SENAT MV, Affres H, Letourneau A, Coustols-Valat M, et al
    Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2018;319:1773-1780.
    PubMed     Text format     Abstract available


  4. COUSTAN DR, Barbour L
    Insulin vs Glyburide for Gestational Diabetes.
    JAMA. 2018;319:1769-1770.
    PubMed     Text format    


    April 2018
  5. ZHENG SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, et al
    Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.
    JAMA. 2018;319:1580-1591.
    PubMed     Text format     Abstract available


  6. SHAPIRO AR
    Continuous Glucose Monitors for Insulin Dosing-Reply.
    JAMA. 2018;319:1384.
    PubMed     Text format    


  7. BECK RW
    Continuous Glucose Monitors for Insulin Dosing.
    JAMA. 2018;319:1383.
    PubMed     Text format    


    March 2018
  8. COGSWELL ME, Loria CM, Terry AL, Zhao L, et al
    Estimated 24-Hour Urinary Sodium and Potassium Excretion in US Adults.
    JAMA. 2018;319:1209-1220.
    PubMed     Text format     Abstract available


  9. DE BOER IH, Bakris G, Cannon CP
    Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations.
    JAMA. 2018 Mar 15. pii: 2675563. doi: 10.1001/jama.2018.0642.
    PubMed     Text format    


    February 2018
  10. MOORE A, Derry S, Wiffen P
    Gabapentin for Chronic Neuropathic Pain.
    JAMA. 2018;319:818-819.
    PubMed     Text format     Abstract available


  11. VOELKER R
    Diabetic Foot Ulcers Heal With Shock Wave Therapy.
    JAMA. 2018;319:649.
    PubMed     Text format    


  12. SCHILLINGER D, Huey N
    Messengers of Truth and Health-Young Artists of Color Raise Their Voices to Prevent Diabetes.
    JAMA. 2018 Feb 14. pii: 2672777. doi: 10.1001/jama.2018.0986.
    PubMed     Text format    


  13. KARGES B, Binder E, Rosenbauer J
    Complications With Insulin Pump Therapy vs Insulin Injection Therapy-Reply.
    JAMA. 2018;319:503-504.
    PubMed     Text format    


    January 2018
  14. IKRAMUDDIN S, Korner J, Lee WJ, Thomas AJ, et al
    Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    JAMA. 2018;319:266-278.
    PubMed     Text format     Abstract available


  15. ABBASI J
    Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes.
    JAMA. 2018;319:215-217.
    PubMed     Text format    


  16. JAKOBSEN GS, Smastuen MC, Sandbu R, Nordstrand N, et al
    Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities.
    JAMA. 2018;319:291-301.
    PubMed     Text format     Abstract available


  17. SALMINEN P, Helmio M, Ovaska J, Juuti A, et al
    Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    JAMA. 2018;319:241-254.
    PubMed     Text format     Abstract available


  18. SHUBECK S, Dimick JB, Telem DA
    Long-term Outcomes Following Bariatric Surgery.
    JAMA. 2018;319:302-303.
    PubMed     Text format    


  19. KNIP M, Akerblom HK, Al Taji E, Becker D, et al
    Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
    JAMA. 2018;319:38-48.
    PubMed     Text format     Abstract available


  20. HAMPTON T
    Smart Artificial Beta Cells May Help Treat Diabetes.
    JAMA. 2018;319:11-12.
    PubMed     Text format    


    December 2017
  21. BANCKS MP, Kershaw K, Carson AP, Gordon-Larsen P, et al
    Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood.
    JAMA. 2017;318:2457-2465.
    PubMed     Text format     Abstract available


  22. RIED-LARSEN M, Johansen MY, Pedersen BK
    Intensive Lifestyle Intervention for Type 2 Diabetes-Reply.
    JAMA. 2017;318:2494-2495.
    PubMed     Text format    


  23. GIUGLIANO D, Maiorino MI, Esposito K
    Intensive Lifestyle Intervention for Type 2 Diabetes.
    JAMA. 2017;318:2494.
    PubMed     Text format    


  24. TING DSW, Cheung CY, Lim G, Tan GSW, et al
    Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
    JAMA. 2017;318:2211-2223.
    PubMed     Text format     Abstract available


    November 2017
  25. SLOMSKI A
    Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  26. SLOMSKI A
    Continuous Glucose Monitoring in Pregnant Women With Diabetes.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  27. KRISCHER JP, Schatz DA, Bundy B, Skyler JS, et al
    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1891-1902.
    PubMed     Text format     Abstract available


  28. LANE W, Bailey TS, Gerety G
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
    JAMA. 2017;318:1828-1829.
    PubMed     Text format    


  29. ZULEWSKI H, Keller U
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes.
    JAMA. 2017;318:1828.
    PubMed     Text format    


  30. SHAHRAZ S, Pittas AG, Saadati M, Thomas CP, et al
    Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014.
    JAMA. 2017;318:1825-1827.
    PubMed     Text format    


    October 2017
  31. SLOMSKI A
    Liraglutide May Reduce Diabetic Kidney Disease.
    JAMA. 2017;318:1532.
    PubMed     Text format    


  32. GAO P, Tang X, Hu Y
    Prediabetes Prevalence in China-Reply.
    JAMA. 2017;318:1612-1613.
    PubMed     Text format    


  33. FU N, Jiang Y, Sun W
    Prediabetes Prevalence in China.
    JAMA. 2017;318:1611-1612.
    PubMed     Text format    


  34. DAVIES M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, et al
    Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1460-1470.
    PubMed     Text format     Abstract available


  35. VOS RC, Rutten GEHM
    Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
    JAMA. 2017;318:1489-1490.
    PubMed     Text format     Abstract available


  36. KARGES B, Schwandt A, Heidtmann B, Kordonouri O, et al
    Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    JAMA. 2017;318:1358-1366.
    PubMed     Text format     Abstract available


  37. HART T, Milner R, Cifu A
    Management of a Diabetic Foot.
    JAMA. 2017;318:1387-1388.
    PubMed     Text format    


    August 2017
  38. JOHANSEN MY, MacDonald CS, Hansen KB, Karstoft K, et al
    Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:637-646.
    PubMed     Text format     Abstract available


  39. KUEHN BM
    Pilot Programs Seek to Integrate Genomic Data Into Practice.
    JAMA. 2017;318:410-412.
    PubMed     Text format    


    July 2017
  40. ZHENG Y, Manson JE, Yuan C, Liang MH, et al
    Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life.
    JAMA. 2017;318:255-269.
    PubMed     Text format     Abstract available


  41. LIPSKA KJ, Krumholz HM
    Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies-Reply.
    JAMA. 2017;318:200-201.
    PubMed     Text format    


  42. VENKER BT
    Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies.
    JAMA. 2017;318:200.
    PubMed     Text format    


  43. RUBIN R
    Starch-Based "Super Food" May Protect Against Variety of Diseases.
    JAMA. 2017;318:112-114.
    PubMed     Text format    


  44. WYSHAM C, Bhargava A, Chaykin L, de la Rosa R, et al
    Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
    JAMA. 2017;318:45-56.
    PubMed     Text format     Abstract available


  45. LANE W, Bailey TS, Gerety G, Gumprecht J, et al
    Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
    JAMA. 2017;318:33-44.
    PubMed     Text format     Abstract available


  46. SEAQUIST ER, Chow LS
    Hypoglycemia in Diabetes: Does Insulin Type Matter?
    JAMA. 2017;318:31-32.
    PubMed     Text format    


    June 2017
  47. ABBASI J
    Can a Diet That Mimics Fasting Turn Back the Clock?
    JAMA. 2017 Jun 28. doi: 10.1001/jama.2017.6648.
    PubMed     Text format    


  48. WANG L, Gao P, Zhang M, Huang Z, et al
    Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013.
    JAMA. 2017;317:2515-2523.
    PubMed     Text format     Abstract available


  49. DABELEA D, D'Agostino R Jr, Mayer-Davis EJ
    Complications of Diabetes Diagnosed in Children and Adolescents-Reply.
    JAMA. 2017;317:2553-2554.
    PubMed     Text format    


  50. IBANEZ-BRURON MC, Solebo AL, Rahi JS
    Complications of Diabetes Diagnosed in Children and Adolescents.
    JAMA. 2017;317:2553.
    PubMed     Text format    


  51. PENG S, Li C, Sun X
    Complications of Diabetes Diagnosed in Children and Adolescents.
    JAMA. 2017;317:2552-2553.
    PubMed     Text format    


  52. LIPSKA KJ, Hirsch IB, Riddle MC
    Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.
    JAMA. 2017 Jun 12. doi: 10.1001/jama.2017.6939.
    PubMed     Text format    


  53. CHEW EY
    Dietary Intake of Omega-3 Fatty Acids From Fish and Risk of Diabetic Retinopathy.
    JAMA. 2017;317:2226-2227.
    PubMed     Text format    


  54. CAUGHEY AB
    Gestational Weight Gain and Outcomes for Mothers and Infants.
    JAMA. 2017;317:2175-2176.
    PubMed     Text format    


  55. GOLDSTEIN RF, Abell SK, Ranasinha S, Misso M, et al
    Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis.
    JAMA. 2017;317:2207-2225.
    PubMed     Text format     Abstract available


    May 2017
  56. ABBASI J
    Increase in Diabetes Cases Among Young People.
    JAMA. 2017;317:2053.
    PubMed     Text format    


    April 2017
  57. SLOMSKI A
    Bariatric Surgery Has Durable Effects in Controlling Diabetes.
    JAMA. 2017;317:1615.
    PubMed     Text format    


  58. BRAGG F, Li L, Chen Z
    Urban-Rural Differences in Diabetes-Associated Mortality in China-Reply.
    JAMA. 2017;317:1689.
    PubMed     Text format    


  59. WANG H, Lai Y
    Urban-Rural Differences in Diabetes in China.
    JAMA. 2017;317:1688-1689.
    PubMed     Text format    


  60. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Text format     Abstract available


    March 2017

  61. Metformin for Prediabetes.
    JAMA. 2017;317:1171.
    PubMed     Text format    


  62. MICHA R, Penalvo JL, Cudhea F, Imamura F, et al
    Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States.
    JAMA. 2017;317:912-924.
    PubMed     Text format     Abstract available


  63. REUSCH JE, Manson JE
    Management of Type 2 Diabetes in 2017: Getting to Goal.
    JAMA. 2017 Mar 1. doi: 10.1001/jama.2017.0241.
    PubMed     Text format    


    February 2017
  64. DABELEA D, Stafford JM, Mayer-Davis EJ, D'Agostino R Jr, et al
    Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood.
    JAMA. 2017;317:825-835.
    PubMed     Text format     Abstract available


  65. EMDIN CA, Khera AV, Natarajan P, Klarin D, et al
    Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
    JAMA. 2017;317:626-634.
    PubMed     Text format     Abstract available


  66. ABBASI J
    Unveiling the "Magic" of Diabetes Remission After Weight-Loss Surgery.
    JAMA. 2017;317:571-574.
    PubMed     Text format    


  67. BRITO JP, Montori VM, Davis AM
    Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.
    JAMA. 2017;317:635-636.
    PubMed     Text format    


  68. XIANG AH
    Association of Maternal Diabetes With Autism in Offspring.
    JAMA. 2017;317:537-538.
    PubMed     Text format    


  69. HAMPTON T
    Drug Under Study for Diabetes a Potential Parkinson Therapy.
    JAMA. 2017;317:465.
    PubMed     Text format    


  70. LACY ME, Wellenius GA, Sumner AE, Correa A, et al
    Association of Sickle Cell Trait With Hemoglobin A1c in African Americans.
    JAMA. 2017;317:507-515.
    PubMed     Text format     Abstract available


    January 2017
  71. LIPSKA KJ, Krumholz HM
    Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?
    JAMA. 2017 Jan 26. doi: 10.1001/jama.2017.0029.
    PubMed     Text format    


  72. LIND M, Polonsky W, Hirsch IB, Heise T, et al
    Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    JAMA. 2017;317:379-387.
    PubMed     Text format     Abstract available


  73. BECK RW, Riddlesworth T, Ruedy K, Ahmann A, et al
    Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    JAMA. 2017;317:371-378.
    PubMed     Text format     Abstract available


  74. DAVIDSON MB
    Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
    JAMA. 2017;317:363-364.
    PubMed     Text format    


  75. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    PubMed     Text format     Abstract available


  76. VOELKER R
    Diabetes Drug Gains New Indication.
    JAMA. 2017;317:247.
    PubMed     Text format    


  77. CHAN M
    China's Burgeoning Epidemic of Diabetes-Associated Mortality.
    JAMA. 2017;317:264-266.
    PubMed     Text format    


    December 2016
  78. KOMAROFF AL
    The Microbiome and Risk for Obesity and Diabetes.
    JAMA. 2016 Dec 22. doi: 10.1001/jama.2016.20099.
    PubMed     Text format    


  79. ABBASI J
    NIH Charts a Path for Nutrition Science.
    JAMA. 2016 Dec 14. doi: 10.1001/jama.2016.18217.
    PubMed     Text format    


  80. MARGULIES KB, McNulty SE, Cappola TP
    Lack of Benefit for Liraglutide in Heart Failure-Reply.
    JAMA. 2016;316:2429-2430.
    PubMed     Text format    


  81. CARBONE S, Arena R, Abbate A
    Lack of Benefit for Liraglutide in Heart Failure.
    JAMA. 2016;316:2429.
    PubMed     Text format    


    November 2016
  82. WONG TY, Bressler NM
    Artificial Intelligence With Deep Learning Technology Looks Into Diabetic Retinopathy Screening.
    JAMA. 2016 Nov 29. doi: 10.1001/jama.2016.17563.
    PubMed     Text format    


  83. GULSHAN V, Peng L, Coram M, Stumpe MC, et al
    Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs.
    JAMA. 2016 Nov 29. doi: 10.1001/jama.2016.17216.
    PubMed     Text format     Abstract available


    October 2016
  84. SLOMSKI A
    Eating Oily Fish May Protect Against Diabetic Retinopathy.
    JAMA. 2016;316:1637.
    PubMed     Text format    


  85. SCHILLINGER D, Jacobson MF
    Science and Public Health on Trial: Warning Notices on Advertisements for Sugary Drinks.
    JAMA. 2016;316:1545-1546.
    PubMed     Text format    


  86. LOTTA LA, Sharp SJ, Burgess S, Perry JR, et al
    Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.
    JAMA. 2016;316:1383-1391.
    PubMed     Text format     Abstract available


    September 2016
  87. SLOMSKI A
    Telemonitoring Helps Keep Diabetes Under Control.
    JAMA. 2016;316:1250.
    PubMed     Text format    


  88. VOELKER R
    Injectable Diabetes Drug Approved.
    JAMA. 2016;316:1142.
    PubMed     Text format    


  89. BERGENSTAL RM, Garg S, Weinzimer SA, Buckingham BA, et al
    Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
    JAMA. 2016 Sep 15. doi: 10.1001/jama.2016.11708.
    PubMed     Text format    


    August 2016
  90. HALL M, Dondo TB, Yan AT, Goodman SG, et al
    Association of Clinical Factors and Therapeutic Strategies With Improvements in Survival Following Non-ST-Elevation Myocardial Infarction, 2003-2013.
    JAMA. 2016 Aug 30. doi: 10.1001/jama.2016.10766.
    PubMed     Text format     Abstract available


  91. BEYERLEIN A, Donnachie E, Ziegler AG
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes--Reply.
    JAMA. 2016;316:883.
    PubMed     Text format    


  92. UZOIGWE OF
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes.
    JAMA. 2016;316:882-3.
    PubMed     Text format    


  93. RAHMOUNE H, Boutrid N, Bioud B
    Association of Infection in Early Life and Risk of Developing Type 1 Diabetes.
    JAMA. 2016;316:882.
    PubMed     Text format    


  94. REISS-BRENNAN B, Brunisholz KD, Dredge C, Briot P, et al
    Association of Integrated Team-Based Care With Health Care Quality, Utilization, and Cost.
    JAMA. 2016;316:826-34.
    PubMed     Text format     Abstract available


  95. AFKARIAN M, Zelnick LR, Hall YN, Heagerty PJ, et al
    Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.
    JAMA. 2016;316:602-10.
    PubMed     Text format     Abstract available


  96. HUA X, Herman WH, Clarke P
    Cost of Antihyperglycemic Medications in the United States--Reply.
    JAMA. 2016;316:665-6.
    PubMed     Text format    


  97. ALATORRE C, Schultz EH, Nelson DR
    Cost of Antihyperglycemic Medications in the United States.
    JAMA. 2016;316:665.
    PubMed     Text format    


  98. CHATTERJEE S
    Laboratory Testing in the Setting of Diabetic Scleredema--Reply.
    JAMA. 2016;316:543.
    PubMed     Text format    


  99. ALTER D
    Laboratory Testing in the Setting of Diabetic Scleredema.
    JAMA. 2016;316:542.
    PubMed     Text format    


  100. MARGULIES KB, Hernandez AF, Redfield MM, Givertz MM, et al
    Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
    JAMA. 2016;316:500-8.
    PubMed     Text format     Abstract available


    July 2016
  101. LIPSKA KJ
    JAMA PATIENT PAGE. Diabetes in Older People.
    JAMA. 2016;316:362.
    PubMed     Text format    


  102. MENKE A, Casagrande S, Cowie CC
    Prevalence of Diabetes in Adolescents Aged 12 to 19 Years in the United States, 2005-2014.
    JAMA. 2016;316:344-5.
    PubMed     Text format    


  103. PALMER SC, Mavridis D, Nicolucci A, Johnson DW, et al
    Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis.
    JAMA. 2016;316:313-24.
    PubMed     Text format     Abstract available


    May 2016
  104. CREATORE MI, Glazier RH, Moineddin R, Fazli GS, et al
    Association of Neighborhood Walkability With Change in Overweight, Obesity, and Diabetes.
    JAMA. 2016;315:2211-20.
    PubMed     Text format     Abstract available


  105. RUNDLE AG, Heymsfield SB
    Can Walkable Urban Design Play a Role in Reducing the Incidence of Obesity-Related Conditions?
    JAMA. 2016;315:2175-7.
    PubMed     Text format    


    March 2016
  106. YEH RW, Secemsky EA, Kereiakes DJ, Normand ST, et al
    Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.
    JAMA. 2016 Mar 29. doi: 10.1001/jama.2016.3775.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: